CD8A and viral infectious disease: In the present case, cephalexin was administered in the presence of viral symptoms, which may have resulted in excessive activation of CD4+ and CD8+ T-cells due to the viral infection, coupled with an immune response to the drug, ultimately leading to AGEP onset.